FDA
-
-
-
-
-
-
-
Jaguar Health crofelemer shows PS reductions in pediatric IF patients
-
-
-
-
-
-
-
Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filam
-
-
-
-
-
-
-
Jaguar Health discusses FDA breakthrough therapy designation for rare disease treatment
-
-
-
-
-
-
-
Jaguar Health completes dog diarrhea drug effectiveness trial
-
-
-
-
-
-
-
Jaguar Health receives $3 million from Future Pak after terminating buyback option
-
-
-
-
-
-
-
Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million
-
-
-
-
-
-
-
FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
-
330,535 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

